Blocking TGFβ with inhibitors, neutralizing antibodies, antisense oligonucleotides, or synthetic oligodeoxynucleotides (41, 257–261) can attenuate renal fibrosis in UUO models. This evidence concerns the gene TGFB1 and renal fibrosis.